Abstract:Background Diagnosis of colorectal cancer (CRC) during early stages can greatly improve patient outcome. Although technical advances in the field of genomics and proteomics have identified a number of candidate biomarkers for non-invasive screening and diagnosis, developing more sensitive and specific methods with improved cost-effectiveness and patient compliance has tremendous potential to help combat the disease. Methods We enrolled three cohorts of 479 subjects, including 226 CRC cases, 197 healthy controls, and 56 advanced precancerous lesions (APC). In the discovery cohort, we used quantitative mass spectrometry to measure the expression profile of plasma proteins and applied machine-learning to select candidate proteins. We then developed a targeted mass spectrometry assay to measure plasma concentrations of seven proteins and a logistic regression classifier to distinguish CRC from healthy subjects. The classifier was further validated using two independent cohorts. Results The seven-protein panel consisted of leucine rich alpha-2-glycoprotein 1 (LRG1), complement C9 (C9), insulin-like growth factor binding protein 2 (IGFBP2), carnosine dipeptidase 1 (CNDP1), inter-alpha-trypsin inhibitor heavy chain 3 (ITIH3), serpin family A member 1 (SERPINA1), and alpha-1-acid glycoprotein 1 (ORM1). The panel classified CRC and healthy subjects with high accuracy, since the area under curve (AUC) of the training and testing cohort reached 0.954 and 0.958. The AUC of the two independent validation cohorts was 0.905 and 0.909. In one validation cohort, the panel had an overall sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of 89.9%, 81.8%, 89.2%, and 82.9%, respectively. In another blinded validation cohort, the panel classified CRC from healthy subjects with a sensitivity of 81.5%, specificity of 97.9%, and overall accuracy of 92.0%. Finally, the panel was able to detect APC with a sensitivity of 49%. Conclusions This seven-protein classifier is a clear improvement compared to previously published blood-based protein biomarkers for detecting early-stage CRC, and is of translational potential to develop into a clinically useful assay.

[Establish Predictive Model of Colorectal Cancer by Using Surface Enhanced Laser Desorption/ionization-Time of Flight-Mass Spectrometry].

Proteomic Diagnosis Models from Serum for Early Detection of Oral Squamous Cell Carcinoma.

[Application of SELDI-TOF-MS in Detection of Liver Metastasis from Colorectal Cancer].

Establishment of Serum Protein Pattern for Screening Colorectal Cancer Using SELDI-TOF-MS.

Research on the biomarkers for the prediction of efficacy in first-line chemotherapy of metastatic colorectal cancer using SELDI-TOF-MS

A Serum Proteomic Pattern for the Detection of Colorectal Adenocarcinoma Using Surface Enhanced Laser Desorption and Ionization Mass Spectrometry

Study of distinct serum proteomics for the biomarkers discovery in colorectal cancer.

Research on the differential expression of proteomics models of colorectal cancer, colorectal benign disease and healthy people

Establishing Diagnostic Model of Serum Protein Fingerprinting Patterns for Henatic Metastasis of Coloretal Carcinoma and Its Clinical Application

Establishing a model of classification tree for stage I colorectal cancer using surface-enhanced laser desorption ionization time-of-flight mass spectrometry

Differential Expression of Proteomics Models of Colorectal Cancer, Colorectal Benign Disease and Healthy Controls

Protein Fingerprint of Colorectal Cancer, Adenomatous Polyps, and Normal Mucosa Using ProteinChip Analysis on Laser Capture Microdissected Cells.

Preoperatively Molecular Staging with CM10 ProteinChip and SELDI-TOF-MS for Colorectal Cancer Patients

Identification of Colorectal Cancer Using Proteomic Patterns in Serum

Construction of the classification tree model of colorectal cancer with lymphatic metastasis by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry

[Classification and Diagnostic Prediction of Colorectal Cancer Using Protein Profiling of Serum and Bioinformatics].

A study on the serum proteomics in patients of colorectal cancer

Predicting Metachronous Liver Metastasis From Colorectal Cancer Using Serum Proteomic Fingerprinting

Artificial Neural Networks Analysis Of Surface-Enhanced Laser Desorption/Ionization Mass Spectra Of Serum Protein Pattern Distinguishes Colorectal Cancer From Healthy Population

[Establishment of serum protein pattern model for screening pancreatic cancers by SELDI-TOF-MS technique]

A Proteomic Classifier Panel for Early Screening of Colorectal Cancer: a Case Control Study